By Giri Viswanathan and Jamie Gumbrecht, CNN (CNN) — The US Food and Drug Administration is sharing a new warning about the risks of probiotics for hospitalized preterm infants. The products have been linked with over two dozen reported adverse events since 2018 and one death in 2023, the agency said. On Thursday, the agency announced it had sent a warning letter to manufacturer Abbott Laboratories for their Similac Probiotic Tri-Blend product, which the FDA described as an unapproved new drug and unlicensed biological product. The company agreed to discontinue sales of the product, the agency said. In a statement on Friday, Abbott said that the issue “pertains to a single probiotic a
Hence then, the article about after infant s death fda sends new warning about probiotics for premature babies was published today ( ) and is available onNews channel ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( After infant’s death, FDA sends new warning about probiotics for premature babies )